Applied Therapeutics (APLT)

• Market cap: $14.8M
• 1 day: 7.64%
• 5 days: 2.8%
• 1 month: 5.87%
• 3 months: -90.9%
• 6 months: -76.11%
• Year to date: 0.1%
• 1 year: -82.67%
• 5 years: -99.6%
• 10 years: -98.91%
• Sector: Healthcare
• Industry: Biotechnology

About: Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Employees: 28